Pills

This is the text extract for Schedule Update - effective 1 June 2013 , browse documents here.


Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 June 2013

Cumulative for May and June 2013 Section H cumulative for April, May and June 2013


Contents

Summary of PHARMAC decisions effective 1 June 2013 ................................ 3 Blood glucose test meter reminder ............................................................... 4 Bosentan new listing ..................................................................................... 4 Metolazone ................................................................................................... 4 Lax-Sachets out-of-stock ............................................................................... 4 Amoxycillin 125 mg per 5 ml out-of-stock .................................................... 5 Ticagrelor funding decision delayed .............................................................. 5 News in brief ................................................................................................. 5 Tender News .................................................................................................. 6 Looking Forward ........................................................................................... 6 Sole Subsidised Supply products cumulative to June 2013 ........................... 8 New Listings ................................................................................................ 20 Changes to Restrictions ............................................................................... 21 Changes to Subsidy and Manufacturer’s Price............................................. 24 Changes to General Rules............................................................................ 25 Changes to Brand Name ............................................................................. 27 Changes to Section I ................................................................................... 28 Delisted Items ............................................................................................. 29 Items to be Delisted .................................................................................... 31 Section H changes to Part II ........................................................................ 33 Index ........................................................................................................... 37

2


Summary of PHARMAC decisions

EFFECTIVE 1 JUNE 2013 New listings (page 20) • Macrogol 3350 (Movicol) powder 13.125g, sachets – Special Authority – Retail pharmacy • Bosentan (pms-Bosentan) tab 62.5 mg and 125 mg – Special Authority – Retail pharmacy • Aminoacid formula without phenylalanine (PKU Anamix Junior) powder (unflavoured), 29g – Special Authority – Hospital pharmacy [HP3] • High fat low carbohydrate formula (KetoCal 4:1) powder (unflavoured) – Special Authority – Retail pharmacy Changes to restrictions (pages 21-23) • Acarbose – remove brand switch fee • Metolazone – amend Special Authority criteria • Ethinyloestradiol with levonorgestrel – remove brand switch fee • Lamivudine – remove brand switch fee • Entacapone – remove brand switch fee • Metoclopramide hydrochloride – addition of note – For metoclopramide oral liquid formulation refer, page 188 • Choramphenicol eye drops 0.5% – addition of note – Funded for use in the ear • Eye preparations – Change to restriction • Pilocarpine eye drops 4% – addition of note – subsidised for oral use pursuant to the Standard Formulae Decreased subsidy (page 24) • Amiodarone hydrochloride (Cordarone-X) inj 50 mg per ml, 3ml ampoule • Malathion with permethrin and piperonyl butoxide (Para Plus) spray 0.25% with permethrin 0.5% and piperonyl butoxide 2%, 90 g OP Increased subsidy (page 24) • Metyparone (Metopirone) cap 250 mg • Methylcellulose (Midwest) powder, 100 g • Praziquantel (Biltricide) tab 600 mg

3


4 Pharmaceutical Schedule - Update News

Blood glucose test meter reminder

A reminder that brand change transition arrangements for blood glucose diagnostic test meters will conclude 30 June 2013. These include: • The Brand Switch Fee payable for CareSens meters. • The provision for Pharmacist prescribing of CareSens meters. Qualifying patients will need to present a prescription from their doctor or diabetes nurse to receive a funded meter from 1 July 2013. • Patient co-payment for CareSens meters. A co-payment will be required on meters dispensed from 1 July 2013.

Bosentan new listing

Pms-Bosentan (bosentan) 62.5 mg and 125 mg tablets will be listed fully funded from 1 June 2013 subject to existing Special Authority criteria for bosentan.

Metolazone

The Special Authority criteria for metolazone will be amended from 1 June 2013 to better reflect current practice. Metolazone will be funded for patients with refractory heart failure who are intolerant or have not responded to loop diuretics and/or loop-thiazide combination therapy.

Lax-Sachets out - of - stock

There is expected to be a stock supply issue for Lax-Sachets (macrogol 3350). Movicol sachets will be listed fully funded subject to Special Authority from June 2013 to cover the shortfall in stock. Lax-Sachets sole supply has been suspended until further notice.


Pharmaceutical Schedule - Update News

5

Amoxycillin 125 mg per 5 ml out - of - stock

Ospamox (amoxycillin) 125 mg per 5 ml oral liquid supplied by Sandoz is currently out - of - stock. Pharmacists can dispense the 250 mg per 5 ml strength product and can claim wastage where applicable.

Ticagrelor funding decision delayed

PHARMAC sought feedback on a proposal to list ticagrelor from 1 June 2013 for patients diagnosed with acute coronary syndromes who meet the Special Authority criteria. This proposal is still being considered and will not be listed from 1 June 2013.

News in brief

• Pedialyte Fruit and Pedialyte Plain will be delisted 1 July 2013 due to supplier discontinuation. • Ventolin and Broncolin brands of salbutamol oral liquid 2 mg per 5 ml will be delisted on 1 August 2013 due to supplies of the Salapin brand now being available. • Dr Edward Coughlan has been added to the anti-retroviral prescribers list. • Metoclopramide oral liquid 1 mg per ml will be added to the list of pharmaceuticals with standardised formula for compounding in Ora products from 1 June 2013. • Brand name changes – Pepti Junior Gold (Karicare) to Gold Pepti Junior (Aptamil) and Karicare Food Thickener to Aptamil Feed Thickener. • Due to a stock supply issue the Brand Switch Fee that applies to the Alphapharm brand of zidovudine with lamivudine tablets has been extended, it will now be delisted 1 July 2013. • The proposal to list preservative free eye drops is still being considered, delaying the decision to list from 1 June 2013. • Chloramphenicol eye drops 0.5% will be funded for use in the ear.


Tender News

Sole Subsidised Supply changes – effective 1 July 2013

Chemical Name Baclofen Nortriptyline hydrochloride Nortriptyline hydrochloride Oxybutynin Oxybutynin Quinapril Quinapril Quinapril Presentation; Pack size Tab 10 mg; 100 tab Tab 10 mg; 100 tab Tab 25 mg; 180 tab Oral liq 5 mg per 5 ml; 473 ml Tab 5 mg; 500 tab Tab 5 mg; 90 tab Tab 10 mg; 90 tab Tab 20 mg; 90 tab Sole Subsidised Supply brand (and supplier) Pacifen (Mylan) Norpress (Mylan) Norpress (Mylan) Apo-Oxybutynin (Apotex) Apo-Oxybutynin (Apotex) Arrow-Quinapril 5 (Arrow) Arrow-Quinapril 10 (Arrow) Arrow-Quinapril 20 (Arrow)

Looking Forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Possible decisions for future implementation 1 July 2013 • Adalimumab (Humira, HumiraPen) 40 mg per 0.8 ml prefilled pen and syringe – listing new strength (20 mg per 0.4 ml prefilled pen) and widening access via amendment of Special Authority • Amiloride hydrochloride (Apo – Amiloride) tab 5 mg – new listing • Cetomacrogol with glycerol (Pharmacy Health) crm 90% with glycerol 10% – new listing • Hyoscine (scopolamine) patches – amend Special Authority criteria • Pegfilgrastim (Neulastim) Inj 6 mg per 0.6 ml – new listing – Special Authority – Retail pharmacy • Phenobarbitone sodium (Martindale) inj 200 mg per ml, 1 ml ampoule – new listing – S29 – Special Authority – Retail pharmacy • Nitrazepam (Nitrados) tab 5 mg – subsidy increase • Ursodeoxycholic acid – amend Special Authority criteria

(continued)

6


Possible decisions for future implementation 1 July 2013 (continued) • Special foods – amendment of Special Authority criteria for the following: • • • • • • • • • • • • • Carbohydrate Fat Protein Carbohydrate and Fat Specialised and Elemental Products Adult Products High Calorie High Protein Products Paediatric Products Extensively Hydrolysed formula Fat Modified Products Renal Products Paediatric Products For Children With Chronic Renal Failure Respiratory Products

7


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Abacavir sulphate Acarbose Acetazolamide Acetylcysteine Aciclovir Allopurinol Amantadine hydrochloride Aminophylline Amitriptyline Amlodipine Amoxycillin Amoxycillin clavulanate

Presentation

Oral liq 20 mg per ml Tab 300 mg Tab 50 mg and 100 mg Tab 250 mg Inj 200 mg per ml, 10 ml Tab dispersible 200 mg, 400 mg & 800 mg Tab 100 mg & 300 mg Cap 100 mg Inj 25 mg per ml, 10 ml Tab 10 mg Tab 25 mg & 50 mg Tab 2.5 mg Tab 5 mg & 10 mg Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml Tab 500 mg with potassium clavulanate 125 mg Crm Tab 100 mg Tab 100 mg Tab dispersible 300 mg Tab 50 mg & 100 mg Tab 10 mg, 20 mg, 40 mg & 80 mg Inj 600 mcg, 1 ml Tab 50 mg Inj 50 mg Tab 500 mg Tab 2.5 mg & 5 mg Inj 1.2 mega u per 2.3 ml Inj 600 mg Eye drops 0.5% Eye drops 0.25%

Brand Name Expiry Date*

Ziagen Ziagen Accarb Diamox Martindale Acetylcysteine Lovir Apo-Allopurinol Symmetrel DBL Aminophylline Arrow-Amitriptyline Amitrip Apo-Amlodipine Apo-Amlodipine Ibiamox Alphamox Augmentin Augmentin Curam Duo AFT Vitala-C Ethics Aspirin EC Ethics Aspirin Mylan Atenolol Zarator AstraZeneca Imuprine Imuran Apo-Azithromycin ArrowBendrofluazide Bicillin LA Sandoz Betoptic Betoptic S 2014 2014 2013 2013 2015 2015 2015 2013 2015 2014 2015 2014 2014 2014 2015 2014 2015 2013 2014 2014 2014 2014 2014 2014 2013 2015

Aqueous cream Ascorbic acid Aspirin Atenolol Atorvastatin Atropine sulphate Azathioprine Azithromycin Bendrofluazide Benzathine benzylpenicillin Benzylpenicillin sodium (Penicillin G) Betaxolol hydrochloride

8

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Bezafibrate Bicalutamide Bisacodyl Bisoprolol fumarate Blood glucose diagnostic test meter Blood glucose diagnostic test strip Brimonidine tartrate Cabergoline Calamine Calcitonin Calcium carbonate Calcium folinate Candesartan Captopril Cefaclor monohydrate Cefazolin sodium Ceftriaxone sodium Cefuroxime sodium Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate

Presentation

Tab 200 mg Tab long-acting 400 mg Tab 50 mg Tab 5 mg Tab 2.5 mg, 5 mg & 10 mg Meter with 50 lancets, a lancing device and 10 diagnostic test strips Blood glucose test strips Eye drops 0.2% Tab 0.5 mg Lotn, BP Inj 100 iu per ml, 1 ml Tab 1.25 g (500 mg elemental) Tab eff 1.75 g (1 g elemental) Tab 15 mg Tab 4 mg, 8 mg, 16 mg & 32 mg Tab 12.5 mg, 25 mg & 50 mg Oral liq 5 mg per ml Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 500 mg Inj 1 g Inj 750 mg Crm BP Oral liq 1 mg per ml Tab 10 mg Eye oint 1% Eye drops 0.5% Mouthwash 0.2% Handrub 1% with ethanol 70% Soln 4% Nail-soln 8% Tab 0.5 mg, 2.5 mg & 5 mg Tab 5 mg with hydrochlorothiazide 12.5 mg Tab 250 mg, 500 mg & 750 mg

Brand Name Expiry Date*

Bezalip Bezalip Retard Bicalaccord Lax-Tab Bosvate CareSens N CareSens N POP CareSens II CareSens CareSens N Arrow-Brimonidine Dostinex PSM Miacalcic Arrow-Calcium Calsource DBL Leucovorin Calcium Candestar m-Captopril Capoten Ranbaxy-Cefaclor AFT Veracol Aspen Ceftriaxone Multichem PSM Cetirizine - AFT Zetop Chlorsig Chlorafast healthE healthE Orion Apo-Ciclopirox Zapril Inhibace Plus Cipflox 2015 2014 2013 2013 2015

2015 2014 2015 2015 2014 2014 2014 2015 2013 2013 2014 2013 2014 2013 2014 2015 2015 2014 2015 2013 2013 2014

Ciclopirox olamine Cilazapril Cilazapril with hydrochlorothiazide Ciprofloxacin

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

9


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Citalopram hydrobromide Clarithromycin Clindamycin Clomipramine hydrochloride Clonidine hydrochloride Clopidogrel Clotrimazole

Presentation

Tab 20 mg Tab 500 mg Tab 250 mg Cap hydrochloride 150 mg Tab 10 mg & 25 mg Tab 150 mcg Inj 150 mcg per ml, 1 ml Tab 75 mg Crm 1% Vaginal crm 1% with applicator Vaginal crm 2% with applicator Soln BP Tab 500 mcg Powder for soln for oral use 4.4 g Crm 10% Tab 50 mg Tab 50 mg Oral liq 100 mg per ml Tab 50 mg & 100 mg Tab 2 mg with ethinyloestradiol 35 mcg and 7 inert tabs Nasal spray 10 mcg per dose Tab 1 mg & 4 mg Eye oint 0.1% Eye drops 0.1% Inj 4 mg per ml, 1 ml & 2 ml

Brand Name Expiry Date*

Arrow-Citalopram Apo-Clarithromycin Apo-Clarithromycin Clindamycin ABM Apo-Clomipramine Catapres Apo-Clopidogrel Clomazol Clomazol Clomazol Midwest Colgout Electral Itch-Soothe Nausicalm Cycloblastin Neoral Siterone Ginet 84 Desmopressin-PH&T Douglas Maxidex Maxidex Hospira Maxitrol Maxitrol 2014 2014 2013 2015 2015 2013 2014 2013 2013 2013 2013 2015 2015 2013 2015 2015 2014 2014 2015 2014 2013 2013 2014

Coal tar Colchicine Compound electrolytes Crotamiton Cyclizine hydrochloride Cyclophosphamide Cyclosporin Cyproterone acetate Cyproterone acetate with ethinyloestradiol Desmopressin Dexamethasone

Dexamethasone sodium phosphate

Dexamethasone with neomycin Eye oint 0.1% with neomycin sulphate and polymyxin b sulphate 0.35% and polymyxin B sulphate 6,000 u per g Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml Dexamphetamine sulphate Dextrose Dextrose with electrolytes Tab 5 mg Inj 50%, 10 ml Soln with electrolytes

PSM Biomed Pedialyte – Fruit Pedialyte – Bubblegum Pedialyte – Plain

2015 2014 2013

10

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Diclofenac sodium

Presentation

Tab EC 25 mg & 50 mg Tab long-acting 75 mg & 100 mg Inj 25 mg per ml, 3 ml Eye drops 1 mg per ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab long-acting 60 mg Cap long-acting 120 mg, 180 mg & 240 mg Tab 30 mg & 60 mg Tab long-acting 150 mg Cap 50 mg Cap 120 mg Tab 50 mg with total sennosides 8 mg Tab 10 mg Tab 2 mg & 4 mg Tab 100 mg Oint BP Tab 5 mg, 10 mg & 20 mg Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Inj 500 mcg per ml, 1 ml Tab 10 mg & 20 mg Tab 200 mg Tab 10 mcg Tab 20 mcg with levonorgestrel 100 mcg & 7 inert tab Tab 30 mcg with levonorgestrel 150 mcg & 7 inert tab Tab 25 mg Tab long-acting 5 mg & 10 mg Tab long-acting 2.5 mg Transdermal patch 12.5 mcg per hour, 25 mcg per hour, 50 mcg per hour, 75 mcg per hour, 100 mcg per hour Inj 50 mcg per ml, 2 ml & 10 ml Oral liq 30 mg per 1 ml (6 mg elemental per 1 ml)

Brand Name Expiry Date*

Apo-Diclo Diclax SR Voltaren Voltaren Ophtha Voltaren DHC Continus Apo-Diltiazem CD Dilzem Pytazen SR Laxofast 50 Laxofast 120 Laxsol Prokinex Apo-Doxazosin Doxine AFT m-Enalapril Clexane Entapone DBL Ergometrine Loxalate Arrow-Etidronate NZ Medical and Scientific Ava 20 ED Ava 30 ED Aromasin Plendil ER Plendil ER Mylan Fentanyl Patch 2014 2015 2013 2014 2014 2013 2015 2014 2014 2014 2015 2015 2015 2014 2013 2015 2015 2014 2015 2014

Dihydrocodeine tartrate Diltiazem hydrochloride

2013 2015

Dipyridamole Docusate sodium Docusate sodium with sennosides Domperidone Doxazosin mesylate Doxycycline hydrochloride Emulsifying ointment Enalapril Enoxaparin sodium Entacapone Ergometrine maleate Escitalopram Etidronate disodium Ethinyloestradiol Ethinyloestradiol with levonorgestrel

Exemestane Felodopine Fentanyl

Fentanyl citrate Ferrous sulphate

Boucher and Muir Ferodan

2015 2013

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

11


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Filgrastim Finasteride Flucloxacillin sodium

Presentation

Inj 300 mcg per 0.5 ml Inj 480 mcg per 0.5 ml Tab 5 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 250 mg & 500 mg Inj 250 mg, 500 mg & 1 g Cap 50 mg, 150 mg & 200 mg Eye drops 0.1% Crm 5% Cap 20 mg Tab dispersible 20 mg, scored Tab 250 mg Metered aqueous nasal spray, 50 mcg per dose Tab 500 mg Tab 40 mg Inj 10 mg per ml, 2 ml Crm 2% Oint 2% Tab 600 mg Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Suppos 3.6 g Liquid Aerosol spray 400 mcg per dose TDDS 5 mg & 10 mg Tab 600 mcg Inj 5 mg per ml, 1 ml Oral liq 2 mg per ml Tab 500 mcg, 1.5 mg & 5 mg Tab 5 mg & 20 mg Crm 1% Powder Inj 50 mg per ml, 1 ml Rectal foam 10%, CFC-Free (14 applications) Lipocream 0.1% Milky emul 0.1% Oint 0.1% Scalp lotn 0.1%

Brand Name Expiry Date*

Zarzio Zarzio Rex Medical AFT Staphlex Flucloxin Ozole Flucon Efudix Fluox Fluox Flutamin Flixonase Hayfever & Allergy Urex Forte Diurin 40 Frusemide-Claris Foban Foban Lipazil Pfizer Apo-Gliclazide Minidiab PSM healthE Glytrin Nitroderm TTS Lycinate Serenace Serenace Serenace Douglas Pharmacy Health ABM Solu-Cortef Colifoam Locoid Lipocream Locoid Crelo Locoid Locoid

31/12/15

2014 2015 2014 2014 2015 2015 2013 2013 2015 2015 2013 2013 2013 2015 2014 2015 2015 2013 2014

Fluconazole Fluorometholone Fluorouracil sodium Fluoxetine hydrochloride Flutamide Fluticasone propionate Furosemide

Fusidic acid Gemfibrozil Gentamicin sulphate Gliclazide Glipizide Glycerol Glyceryl trinitrate

Haloperidol

2013

Hydrocortisone

2015 2014 2013 2015 2015

Hydrocortisone acetate Hydrocortisone butyrate

12

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Hydrocortisone with miconazole Hydrocortisone with wool fat and mineral oil Hydroxocobalamin Hydroxychloroquine sulphate Hyoscine N-butylbromide Ibuprofen

Presentation

Crm 1% with miconazole nitrate 2% Lotn 1% with wool fat hydrous 3% and mineral oil Inj 1 mg per ml, 1 ml Tab 200 mg Inj 20 mg, 1 ml Tab 10 mg Tab 200 mg Tab long-acting 800 mg Oral liq 100 mg per 5 ml Crm 5% Tab 2.5 mg Aqueous nasal spray, 0.03%, 15 ml OP Nebuliser soln, 250 mcg per ml, 1 ml & 2 ml Inj 50 mg per ml, 2 ml Tab 100 mg Tab 20 mg Tab long-acting 40 mg Cap 10 mg & 20 mg Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml Tab 100 mg Oral liq 10 mg per ml Tab 150 mg Cap 15 mg & 30 mg Eye drops 50 mcg per ml Tab 2.5 mg Subdermal implant (2 x 75 mg rods) Viscous soln 2% Inj 1%, 5 ml & 20 ml Crm 2.5% with prilocaine 2.5% (5 g tubes) Crm 2.5% with prilocaine 2.5%; 30 g OP Tab 5 mg, 10 mg & 20 mg

Brand Name Expiry Date*

Micreme H DP Lotn HC ABM Hydroxocobalamin Plaquenil Buscopan Gastrosoothe Arrowcare Brufen SR Fenpaed Aldara Dapa-Tabs Univent Univent Ferrum H PSM Ismo 20 Corangin Oratane Itrazole Sebizole Laevolac Zetlam 3TC 3TC Solox Hysite Letraccord Jadelle Xylocaine Viscous Xylocaine EMLA EMLA Arrow-Lisinopril 2015 2014 2015 2014 2015 2013 2014 2013 2014 2013 2015 2015 2015 31/12/13 2014 2013 2013 2013 2014 2015 2015 2014 2014 2013 2014 2013 2013

Imiquimod Indapamide Ipratropium bromide

Iron polymaltose Isoniazid Isosorbide mononitrate Isotretinoin Itraconazole Ketoconazole Lactulose Lamivudine

Lansoprazole Latanoprost Letrozole Levonorgestrel Lignocaine hydrochloride Lignocaine with prilocaine

Lisinopril

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

13


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Lithium carbonate Lodoxamide trometamol Loperamide hydrochloride Loratadine

Presentation

Tab 250 mg & 400 mg Cap 250 mg Eye drops 0.1% Cap 2 mg Oral liq 1 mg per ml Tab 10 mg Tab 1 mg & 2.5 mg Tab 12.5 mg, 25 mg, 50 mg & 100 mg Tab 50 mg with hydrochlorothiazide 12.5 mg Liq 0.5% Shampoo 1% Size 2 Tab 100 mg Tab 135 mg Tab 160 mg Tab 4 mg & 100 mg Inj 40 mg per ml Inj 40 mg per ml with lignocaine 1 ml Tab 50 mg Enema 1 g per 100 ml Suppos 500 mg Tab immediate-release 500 mg & 850 mg Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab 5 mg Inj 25 mg per ml, 2 ml & 20 ml Inj 40 mg per ml, 1 ml; 62.5 mg per ml, 2 ml; 500 mg & 1 g Inj 5 mg per ml, 2 ml Tab 10 mg Tab long-acting 23.75 mg, 47.5 mg, 95 mg & 190 mg Inj 1 mg per ml, 5 ml Tab 50 mg & 100 mg Tab long-acting 200 mg

Brand Name Expiry Date*

Lithicarb FC Douglas Lomide Diamide Relief Lorapaed Loraclear Hayfever Relief Ativan Lostaar Arrow-Losartan & Hydroclorothiazide A-Lices A-Lices EZ-fit Paediatric Mask De-Worm Colofac Apo-Megestrol Medrol Depo-Medrol Depo-Medrol with Lidocaine Purinethol Pentasa Asacol Apotex Biodone Biodone Forte Biodone Extra Forte Methatabs Hospira Solu-Medrol Pfizer Metamide Metoprolol-AFT CR Lopresor Lopresor Slow-Lopresor 2015 2014 2014 2013 2013

Lorazepam Losartan Losartan with hydrochlorothiazide Malathion Mask for spacer device Mebendazole Mebeverine hydrochloride Megestrol acetate Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Mercaptopurine Mesalazine Metformin hydrochloride Methadone hydrochloride

2013 2014 2014 2013 2015 2014 2014 2015 2015 2015 2015 2013 2015 2014 2015 2015 2013 2013 2015 2014 2015 2015

Methotrexate Methylprednisolone sodium succinate Metoclopramide hydrochloride Metoprolol succinate Metoprolol tartrate

14

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Miconazole Miconazole nitrate Mirtazapine Moclobemide Mometasone furoate Morphine hydrochloride Morphine sulphate

Presentation

Oral gel 20 mg per g Crm 2% Tab 30 mg & 45 mg Tab 150 mg & 300 mg Crm 0.1% Oint 0.1% Oral liq 1 mg per ml, 2 mg per ml, 5 mg per ml & 10 mg per ml Inj 5 mg per ml, 1 ml Inj 10 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Tab long-acting 10 mg, 30 mg, 60 mg & 100 mg Cap long-acting 10 mg, 30 mg, 60 mg & 100 mg

Brand Name Expiry Date*

Decozol Multichem Avanza Apo-Moclobemide m-Mometasone RA-Morph DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate Arrow-Morphine LA m-Elson Hospira Konsyl-D Naphcon Forte Apo-Nadolol Noflam 250 Noflam 500 Naltraccord AstraZeneca Nevirapine Alphapharm Habitrol Habitrol Habitrol Apo-Nicotinic Acid Arrow-Norfloxacin Noriday 28 Primolut N Nilstat Nilstat Nilstat 2014 2014 2015 2014 2014 2013 2013 2013 2014 2015 2015 2013 2014 2015 2014 2015 2014 2015 2015 2015 2015 2014

2013

Morphine tartrate Mucilaginous laxatives Naphazoline hydrochloride Nadolol Naproxen Naltrexone hydrochloride Neostigmine Nevirapine Nicotine

Inj 80 mg per ml, 1.5 ml & 5 ml Dry Eye drops 0.1% Tab 40 mg & 80 mg Tab 250 mg Tab 500 mg Tab 50 mg Inj 2.5 mg per ml, 1 ml Tab 200 mg Gum 2 mg & 4 mg (classic, fruit, mint) Lozenge 1 mg & 2 mg Patch 7 mg, 14 mg & 21 mg Tab 50 mg & 500 mg Tab 400 mg Tab 350 mcg Tab 5 mg Oral liq 100,000 u per ml Cap 500,000 u Tab 500,000 u

Nicotinic acid Norfloxacin Norethisterone Nystatin

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

15


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Octreotide (somatostatin analogue) Oil in water emulsion Omeprazole

Presentation

Inj 50 mcg per ml, 1 ml Inj 100 mcg per ml, 1 ml Inj 500 mcg per ml, 1 ml Crm Cap 10 mg, 20 mg & 40 mg Powder Inj 40 mg Tab disp 8 mg Tab 4 mg & 8 mg

Brand Name Expiry Date*

Octreotide Max Rx 2014

healthE Fatty Cream Omezol Relief Midwest Dr Reddy’s Omeprazole Dr Reddy’s Ondansetron Dr Reddy’s Ondansetron Ox-Pam OxyNorm Oxycodone Orion Syntometrine Pamidronate BNM Pantocid IV Dr Reddy’s Pantoprazole Paracare Parafast Ethics Paracetamol Paracare Double Strength Paracetamol + Codeine (Relieve) Lacri-Lube Loxamine Breath-Alert Permax Lyderm A-Scabies PSM DBL Pethidine Hydrochloride DBL Pethidine Hydrochloride PSM

2015 2014

Ondansetron

2013

Oxazepam Oxycodone hydrochloride Oxytocin Pamidronate disodium Pantoprazole

Tab 10 mg & 15 mg Inj 50 mg per ml, 1 ml Inj 10 mg per ml, 1 ml & 2 ml Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml Inj 3 mg per ml, 10 ml; 6 mg per ml, 10 ml & 9 mg per ml, 10 ml Inj 40 mg Tab 20 mg & 40 mg Suppos 500 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Tab paracetamol 500 mg with codeine phosphate 8 mg Eye oint with soft white paraffin Tab 20 mg Low range & normal range Tab 0.25 mg & 1 mg Crm 5% Lotn 5% Tab 50 mg & 100 mg Inj 50 mg per ml, 1 ml Inj 50 mg per ml, 2 ml

2014 2015 2015 2014 2014 2013 2015 2014

Paracetamol

Paracetamol with codeine Paraffin liquid with soft white paraffin Paroxetine hydrochloride Peak flow meter Pergolide Permethrin Pethidine hydrochloride

2014 2013 2013 2015 2014 2014 2015 2014

Phenobarbitone

Tab 15 mg & 30 mg

2015

16

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Phenoxymethylpenicillin (Pencillin V)

Presentation

Cap potassium salt 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Tab 15 mg, 30 mg & 45 mg Tab 500 mcg Oral drops 10% Tab long-acting 600 mg Tab 0.125 mg & 0.25 mg Tab 20 mg & 40 mg Inj 1.5 mega u Oral liq 5 mg per 5 ml Tab 10 mg & 25 mg Tab 60 mg Tab 25 mg Tab 50 mg Tab 10 mg with hydrochlorothiazide 12.5 mg Tab 20 mg with hydrochlorothiazide 12.5 mg Oral liq 150 mg per 10 ml Tab 150 mg & 300 mg Cap 150 mg Tab 100 mg Tab orodispersible 10 mg Tab 0.25 mg, 1 mg, 2 mg & 5 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml & 2 mg per ml, 2.5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml Tab 50 mg & 100 mg Tab 25 mg, 50 mg & 100 mg Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg Inj 23.4%, 20 ml

Brand Name Expiry Date*

Cilicaine VK AFT AFT Pizaccord Sandomigran Coloxyl Span-K Dr Reddy’s Pramipexole Cholvastin Cilicaine Allersoothe Allersoothe Mestinon PyridoxADE Apo-Pyridoxine Accuretic 10 Accuretic 20 Peptisoothe Arrow-Ranitidine Mycobutin Norvir Rizamelt Ropin ArrowRoxithromycin Asthalin Duolin 2014 2013 2015 2014 2013 2015 2015 2015 2015 2015 2014 2015 2013 2014 2014 2015 2014 2014 2015 2013

Pioglitazone Pizotifen Poloxamer Potassium chloride Pramipexole hydrochloride Pravastatin Procaine penicillin Promethazine hydrochloride Pyridostigmine bromide Pyridoxine hydrochloride Quinapril with hydrochlorothiazide

Ranitidine hydrochloride Rifabutin Ritonavir Rizatriptan Ropinirole hydrochloride Roxithromycin Salbutamol Salbutamol with ipratropium bromide Sertraline Sildenafil Simvastatin

Arrow-Sertraline Silagra Arrow-Simva 10mg Arrow-Simva 20mg Arrow-Simva 40mg Arrow-Simva 80mg Biomed

2013 2014 2014

Sodium chloride

2013

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

17


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Sodium citrate with sodium lauryl sulphoacetate Sodium citro-tartrate Sodium cromoglycate Spacer device

Presentation

Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml Grans effervescent 4 g sachets Eye drops 2% 800 ml 230 ml (single patient) Tab 25 mg & 100 mg Inj 12 mg per ml, 0.5 ml Tab 50 mg & 100 mg Tab 20 mg Cap 400 mcg Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium, 500 ml & 1,000 ml Tab 10 mg Cap 5 mg, 20 mg, 100 mg & 250 mg Tab 1 mg, 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Cap 40 mg Tab 25 mg Inj 250 mcg Inj 1 mg per ml, 1 ml Eye drops 0.25% & 0.5% Eye drops 0.3% Eye oint 0.3% Inj 40 mg per ml, 2 ml Tab 100 mg Cap 50 mg Inj 10 mg per ml, 1 ml Inj 40 mg per ml, 1 ml Crm 0.02% Oint 0.02% 0.1% in Dental Paste USP Tab 500 mg Eye drops 0.5% & 1% Cap 250 mg Inj 500 mg

Brand Name Expiry Date*

Micolette Ural Rexacrom Volumatic Space Chamber Plus Spirotone Arrow-Sumatriptan Arrow-Sumatriptan Genox Tamsulosin-Rex Pinetarsol 2013 2013 2013 2015

Spironolactone Sumatriptan Tamoxifen citrate Tamsulosin hydrochloride Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Temozolomide Terazosin hydrochloride Terbinafine Testosterone cypionate Testosterone undecanoate Tetrabenazine Tetracosactrin Timolol maleate Tobramycin

2013 2013 2014 2013 2014

Normison Temaccord Arrow Dr Reddy’s Terbinafine Depo-Testosterone Andriol Testocaps Motetis Synacthen Synacthen Depot Arrow-Timolol Tobrex Tobrex DBL Tobramycin Tasmar Arrow-Tramadol Kenacort-A Kenacort-A40 Aristocort Aristocort Oracort Cyklokapron Mydriacyl Ursosan Mylan

2014 2013 2013 2014 2014 2015 2013 2014 2014 2014

Tolcapone Tramadol hydrochloride Triamcinolone acetonide

2014 2014 2014

Tranexamic acid Tropicamide Ursodeoxycholic acid Vancomycin hydrochloride

2013 2014 2014 2014

18

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to June 2013

Generic Name

Verapamil hydrochloride Vitamin B complex Vitamins Zidovudine [AZT] Zidovudine [AZT] with lamivudine Zinc and castor oil Zinc sulphate June changes are in bold type

Presentation

Tab 40 mg & 80 mg Tab, strong, BPC Tab (BPC cap strength) Cap 100 mg Oral liq 10 mg per ml Tab 300 mg with lamivudine 150 mg Oint BP Caps 137.4 mg (50 mg elemental)

Brand Name Expiry Date*

Isoptin B-PlexADE MultiADE Retrovir Retrovir Alphapharm Multichem Zincaps 2014 2013 2013 2013 2014 2014 2014

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

19


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 June 2013

39 MACROGOL 3350 – Special Authority see SA0891 – Retail pharmacy Powder 13.125 g, sachets - Maximum of 60 sach per prescription ......................................................................... 18.14 BOSENTAN – Special Authority see SA0967 – Retail pharmacy Tab 62.5 mg ..................................................................... 2,000.00 Tab 125 mg ...................................................................... 2,000.00

30 60 60

✔Movicol ✔ pms-Bosentan ✔ pms-Bosentan

62

211 213

AMINOACID FORMULA WITHOUT PHENYLALANINE – Special Authority see SA1108 – Hospital pharmacy [HP3] Powder (unflavoured), 29 g .................................................. 330.12 30 ✔ PKU Anamix Junior HIGH FAT LOW CARBOHYDRATE FORMULA – Special Authority see SA1197 – Retail pharmacy Powder (unflavoured) .............................................................. 35.50 300 g OP ✔ KetoCal 4:1

Effective 6 May 2013

72 MALATHION WITH PERMETHRIN AND PIPERONYL BUTOXIDE Spray 0.25% with permethrin 0.5% and piperonyl butoxide 2%......................................................................... 11.95

90 g OP

✔ Para Plus

Effective 1 May 2013

52 57 58 61 119 PERINDOPRIL ❋ Tab 2 mg ................................................................................. 3.75 ❋ Tab 4 mg ................................................................................. 4.80 CLONIDINE HYDROCHLORIDE ❋ Tab 25 mcg............................................................................. 15.09 METOLAZONE – Special Authority see SA1323 – Retail pharmacy Tab 5 mg ............................................................................. CBS 30 30 112 50 ✔ Apo-Perindopril ✔ Apo-Perindopril ✔ Clonidine BNM ✔ Zaroxolyn S29 ✔ Onelink S29 ✔ Lidocaine-Claris ✔ Lidocaine-Claris ✔ BSF Apo-Diltiazem CD

HYDRALAZINE HYDROCHLORIDE – Special Authority see SA1321 – Retail pharmacy ❋ Tab 25 mg ........................................................................... CBS 56 LIDOCAINE [LIGNOCAINE] HYDROCHLORIDE Inj 2%, 5 ml – Up to 5 inj available on a PSO .............................. 6.90 Inj 2%, 20 ml – Up to 5 inj available on a PSO ............................ 2.40 PHARMACY SERVICES – May only be claimed once per patient Brand switch fee ....................................................................... 4.33 The Pharmacode for BSF Apo-Diltiazem CD is 2437775 25 1 1 fee

186

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

20

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 June 2013

29 ACARBOSE – Brand switch fee payable (Pharmacode 2433257) - see page 177 for details ❋ Tab 50 mg ................................................................................ 9.82 90 ✔ Accarb ❋ Tab 100 mg ............................................................................ 15.83 90 ✔ Accarb METOLAZONE – Special Authority see SA1323 – Retail pharmacy Tab 5 mg ............................................................................ CBS

58

50 1

➽SA1323 Special Authority for Subsidy Initial application from any relevant practitioner. Approvals valid without further renewal unless notified where used for applications meeting the following criteria: the treatment of patients with refractory heart failure who are intolerant or have not responded to loop diuretics and/or loop-thiazide combination therapy. Either: 1)For the treatment of heart failure in patients who are intolerant or have not responded to ACE inhibitors and/or angiotensin receptor blockers; or 2)For the treatment of heart failure, in patients in whom treatment with ACE inhibitors and/or angiotensin receptor blockers is not tolerated due to renal impairment. 72 ETHINYLOESTRADIOL WITH LEVONORGESTREL ❋ Tab 20 mcg with levonorgestrel 100 mcg and 7 inert tab – Up to 84 tab available on a PSO – Brand switch fee payable (Pharmacode 2427958) see page 177 for details ........................................................ 2.95 84

✔ Zaroxolyn S29 ✔ Metolazone S29

✔ Ava 20 ED

98

LAMIVUDINE – Special Authority see SA0832 – Retail pharmacy – Brand switch fee payable (Pharmacode 2433257) - see page 177 for details Tab 100 mg ............................................................................ 32.50 28 ✔ Zetlam ENTACAPONE – Brand switch fee payable (Pharmacode 2433249) - see page 177 for details s Tab 200 mg............................................................................ 47.92 100 ✔ Entapone METOCLOPRAMIDE HYDROCHLORIDE ❋ Tab 10 mg – For metoclopramide oral liquid formulation refer, page 188 .............................................................................. 3.95 CHLORAMPHENICOL Eye drops 0.5% ........................................................................ 1.20 Funded for use in the ear* Indications marked with* are Unapproved Indications.

118 131

100 10 ml OP

✔ Metamide ✔ Chlorafast

182

182

EYE PREPARATIONS Eye preparations are only funded for use in the eye, unless explicitly stated otherwise. The exception is pilocarpine eye drops 1%, 2% and 4% which are subsidised for oral use pursuant to the Standard Formulae. PILOCARPINE Eye drops 4% - Subsidised for oral use pursuant to the Standard Formulae .............................................................. 7.99

184

15 ml OP

✔ Isopto Carpine

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

21


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Effective 1 May 2013

52 PERINDOPRIL Perindopril will be funded to the level of the ex-manufacturer price listed in the Schedule for patients who were taking these ACE inhibitors for the treatment of congestive heart failure prior to 1 June 1998. The prescription must be endorsed accordingly. We recommend that the words used to indicate eligibility are "certified condition" or an appropriate description of the patient such as "congestive heart failure", "CHF", "congestive cardiac failure" or "CCF". Definition of Congestive Heart Failure At the request of some prescribers the PTAC Cardiovascular subcommittee has provided a definition of congestive heart failure for the purposes of the funding of the manufacturer’s surcharge: "Clinicians should use their clinical judgement. Existing patients would be eligible for the funding of the surcharge if the patient shows signs and symptoms of congestive heart failure, and requires or has in the past required concomitant treatment with a diuretic. The definition could also be considered to include patients post myocardial infarction with an ejection fraction of less than 40%." ❋ Tab 2 mg – Higher subsidy of $18.50 per 30 tab with Endorsement .................................................................. 3.75 30 ✔ Apo-Perindopril (18.50) Coversyl ❋ Tab 4 mg – Higher subsidy of $25.00 per 30 tab with Endorsement .................................................................. 4.80 30 ✔ Apo-Perindopril (25.00) Coversyl TRANDOLAPRIL Higher subsidy by endorsement is available Trandolapril will be funded to the level of the ex-manufacturer price listed in the Schedule for patients who were taking these ACE inhibitors trandolapril for the treatment of congestive heart failure prior to 1 June 1998. The prescription must be endorsed accordingly. We recommend that the words used to indicate eligibility are "certified condition" or an appropriate description of the patient such as "congestive heart failure", "CHF", "congestive cardiac failure" or "CCF". Definition of Congestive Heart Failure At the request of some prescribers the PTAC Cardiovascular subcommittee has provided a definition of congestive heart failure for the purposes of the funding of the manufacturer's surcharge: "Clinicians should use their clinical judgement. Existing patients would be eligible for the funding of the surcharge if the patient shows signs and symptoms of congestive heart failure, and requires or has in the past required concomitant treatment with a diuretic. The definition could also be considered to include patients post myocardial infarction with an ejection fraction of less than 40%." For the purposes of this endorsement, congestive heart failure includes patients post myocardial infarction with an ejection fraction of less than 40%. Patients who started on trandolapril after 1 June 1998 are not eligible for full subsidy by endorsement. ❋ Cap 1 mg – Higher subsidy of $18.67 per 28 cap with Endorsement .................................................................. 3.06 28 (18.67) Gopten ❋ Cap 2 mg – Higher subsidy of $27.00 per 28 cap with Endorsement .................................................................. 4.43 28 (27.00) Gopten DILTIAZEM HYDROCHLORIDE ❋ Cap long-acting 120 mg – Brand switch fee payable (Pharmacode 2437775) .......... 31.83 ❋ Cap long-acting 180 mg – Brand switch fee payable (Pharmacode 2437775) .......... 47.67 ❋ Cap long-acting 240 mg – Brand switch fee payable (Pharmacode 2437775) .......... 63.58

52

57

500 500 500

✔ Apo-Diltiazem CD ✔ Apo-Diltiazem CD ✔ Apo-Diltiazem CD

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

22

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2013 (continued)

91 CIPROFLOXACIN – Subsidy by endorsement 1) Subsidised only if: a) Patient has: i) microbiologically confirmed and clinically significant pseudomonas infection; or ii) prostatitis; or iii) pyelonephritis; or iv) gonorrhoea; b) Prescription or PSO is written by, or on the recommendation of, an infectious disease physician or a clinical microbiologist; and 2) The prescription or PSO is endorsed accordingly. Recommended for patients with the any of the following: i) microbiologically confirmed and clinically significant pseudomonas infection; or ii) prostatitis; or iii) pyelonephritis; or iv) gonorrhoea; or Tab 250 mg – Up to 5 tab available on a PSO ............................ 2.20 28 ✔ Cipflox Tab 500 mg – Up to 5 tab available on a PSO ............................ 3.00 28 ✔ Cipflox 10.71 100 ✔ Cipflox Tab 750 mg .............................................................................. 5.15 28 ✔ Cipflox 5.52 30 ✔ Ciprofloxacin Rex CLINDAMYCIN Cap hydrochloride 150 mg – Maximum of 4 cap per prescription; can be waived by endorsement – Retail pharmacy-Specialist .... 9.90 16 ✔ Clindamycin ABM Specialist must be an infectious disease physician or a clinical microbiologist Inj phosphate 150 mg per ml, 4 ml – Retail pharmacy-Specialist...160.00 10 ✔ Dalacin C Prescriptions must be written by, or on the recommendation of, an infectious disease physician or a clinical microbiologist. ITRACONAZOLE Cap 100 mg – Subsidy by endorsement .................................... 4.25 15 ✔ Itrazole Funded for tinea vesicolor where topical treatment has not been successful and diagnosis has been confirmed by mycology, or for tinea unguium where terbinafine has not been successful in eradication or the patient is intolerant to terbinafine and diagnosis has been confirmed by mycology and the prescription is endorsed accordingly. Can be waived by endorsement - Retail pharmacy - Specialist. Specialist must be an infectious disease physician, clinical microbiologist, clinical immunologist or dermatologist. ISONIAZID – Retail pharmacy-Specialist a) No patient co-payment payable b) Prescriptions must be written by, or on the recommendation of, an internal medicine physician, paediatrician, clinical microbiologist, dermatologist or public health physician ❋ Tab 100 mg ........................................................................... 20.00 100 ✔ PSM ❋ Tab 100 mg with rifampicin 150 mg ....................................... 90.04 100 ✔ Rifinah ❋ Tab 150 mg with rifampicin 300 mg ..................................... 179.57 100 ✔ Rifinah LIGNOCAINE HYDROCHLORIDE LIDOCAINE [LIGNOCAINE] HYDROCHLORIDE Viscous soln 2%...................................................................... 55.00 200 ml Inj 1%, 5 ml – Up to 5 inj available on a PSO ........................... 35.00 50 Inj 2%, 5 ml – Up to 5 inj available on a PSO ........................... 23.00 50 6.90 25 Inj 1%, 20 ml – Up to 5 inj available on a PSO .......................... 20.00 5 Inj 2%, 20 ml – Up to 5 inj available on a PSO .......................... 15.00 5 2.40 1 ✔ Xylocaine Viscous ✔ Xylocaine ✔ Xylocaine ✔ Lidocaine-Claris ✔ Xylocaine ✔ Xylocaine ✔ Lidocaine-Claris

92

94

96

119

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

23


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 June 2013

53 AMIODARONE HYDROCHLORIDE ( subsidy) Inj 50 mg per ml, 3 ml ampoule – Up to 6 inj available on a PSO..................................................................................... 22.80

6

✔ Cordarone-X

72

MALATHION WITH PERMETHRIN AND PIPERONYL BUTOXIDE ( subsidy) Spray 0.25% with permethrin 0.5% and piperonyl butoxide 2%......................................................................... 11.15 90 g OP METYRAPONE ( subsidy) Cap 250 mg – Retail pharmacy-Specialist ............................. 520.00 PRAZIQUANTEL ( subsidy) Tab 600 mg ........................................................................... 68.00 METHYLCELLULOSE ( subsidy) Powder .................................................................................. 36.95 50 8 100 g

✔ Para Plus ✔ Metopirone ✔ Biltricide ✔ MidWest

87 88 193

Effective 1 May 2013

52 PERINDOPRIL ( subsidy) Tab 2 mg ................................................................................. 3.75 (18.50) Tab 4 mg .................................................................................. 4.80 (25.00) CALAMINE ( price) a) Only on a prescription b) Not in combination Crm, aqueous, BP .................................................................... 1.77 (3.80) LEVONORGESTREL ( subsidy) ❋ Tab 1.5 mg ............................................................................... 3.50 a) Maximum of 2 tab per prescription b) Up to 5 tab available on a PSO 30 Coversyl 30 Coversyl

66

100 g Home Essential 1 ✔ Postinor-1

78

120

CODEINE PHOSPHATE ( subsidy) – Safety medicine; prescriber may determine dispensing frequency Tab 15 mg ................................................................................ 4.75 100 ✔ PSM Tab 30 mg ................................................................................ 5.80 100 ✔ PSM Tab 60 mg .............................................................................. 12.50 100 ✔ PSM AMISULPRIDE ( subsidy) – Safety medicine; prescriber may determine dispensing frequency Tab 100 mg .............................................................................. 6.22 30 ✔ Solian Tab 200 mg ........................................................................... 21.92 60 ✔ Solian Tab 400 mg ........................................................................... 44.52 60 ✔ Solian Oral liq 100 mg per ml ............................................................ 52.50 60 ml ✔ Solian

132

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

24

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to General Rules

Effective 1 May 2013

18 3.3 Original Packs, Certain Antibiotics and Unapproved Medicines 3.3.2 If a Community Pharmaceutical is either: a) the liquid oral form of an antibiotic to which a diluent must be added by the Contractor at the time of dispensing; or b) an unapproved medicine supplied under Section 29 of the Medicines Act 1981 excluding any medicine listed as Cost, Brand, Source of Supply, and it is prescribed or ordered by a Practitioner in an amount that does not coincide with the amount contained in one or more standard packs of that Community Pharmaceutical, Subsidy will be paid for the amount prescribed or ordered by the Practitioner in accordance with either clause 3.1 or clause 3.3 of the Schedule, and for the balance of any pack or packs from which the Community Pharmaceutical has been dispensed. At the time of dispensing the Contractor must keep a record of the quantity discarded. To ensure wastage is reduced, the Contractor should reduce the amount dispensed to make it equal to the quantity contained in a whole pack where: a) the difference the amount dispensed and the amount prescribed by the Practitioner is less than 10% (eg; if a prescription is for 105 mls then a 100 ml pack would be dispensed); and b) in the reasonable opinion of the Contractor the difference would not affect the efficacy of the course of treatment prescribed by the Practitioner. Note: For the purposes of audit and compliance it is an act of fraud to claim wastage and then use the wastage amount for any subsequent prescription.

Effective 1 April 2013

13 “Hospital Pharmacy-Specialist” means that the Community Pharmaceutical is not eligible for Subsidy unless it is supplied by a hospital or pharmacy contracted to the Funder to dispense as a hospital pharmacy to an Outpatient either: a) on a Prescription signed by a Specialist, or b) where the treatment with the Community Pharmaceutical has been recommended by a Specialist, on the Prescription of a practitioner which is either: i) endorsed with the words “recommended by [name of specialist and year of authorisation]” and signed by the Practitioner, or ii) endorsed with the word ‘protocol’ which means “initiated in accordance with DHB hospital approved protocol”, iii) annotated by the dispensing pharmacist, following verbal confirmation from the Practitioner of the name of the Specialist and date of recommendation, with the words “recommended by [name of specialist and date of authorisation], confirmed by [practitioner]”. Where the Contractor has an electronic record of such an Endorsement or Annotation from a previous prescription for the same Community Pharmaceutical written by a prescriber for the same patient, they may annotate the prescription accordingly. “As recommended by a Specialist” to be interpreted as either: 1) a) follows a substantive consultation with an appropriate Specialist; b) the consultation to relate to the Patient for whom the Prescription is written; c) consultation to mean communication by referral, telephone, letter, facsimile or email; d) except in emergencies consultation to precede annotation of the Prescription; and e) both the specialist and the General Practitioner must keep a written record of the consultation; or 2) treatment with the Community Pharmaceutical has been initiated in accordance with a DHB hospital approved protocol

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

25


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to General Rules – effective 1 April 2013 (continued)

15 “Retail Pharmacy-Specialist” means that the Community Pharmaceutical is only eligible for Subsidy if it is either: a) supplied on a Prescription or Practitioner’s Supply Order signed by a Specialist, or, b) in the case of treatment recommended by a Specialist, supplied on a Prescription or Practitioner’s Supply Order and either: i) endorsed with the words “recommended by [name of Specialist and year of authorisation]” and signed by the Practitioner, or ii) endorsed with the word ‘protocol’ which means “initiated in accordance with DHB hospital approved protocol”, or iii) Annotated by the dispensing pharmacist, following verbal confirmation from the Practitioner of the name of the Specialist and date of recommendation, with the words “recommended by [name of specialist and year of authorisation], confirmed by [practitioner]”. Where the Contractor has an electronic record of such an Endorsement or Annotation from a previous prescription for the same Community Pharmaceutical written by a prescriber for the same patient, they may annotate the prescription accordingly. “As recommended by a Specialist” to be interpreted as either: 1) a) follows a substantive consultation with an appropriate Specialist; b) the consultation to relate to the Patient for whom the Prescription is written; c) consultation to mean communication by referral, telephone, letter, facsimile or email; d) except in emergencies consultation to precede annotation of the Prescription; and e) both the Specialist and the General Practitioner must keep a written record of consultation; or 2) treatment with the Community Pharmaceutical has been initiated in accordance with a DHB hospital approved protocol.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

26

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Brand Name

Effective 1 June 2013

209 FOOD THICKENER – Special Authority see SA1106 – Hospital pharmacy [HP3] Powder ..................................................................................... 7.25 380 g OP ✔ Karicare Food Thickener Aptamil Feed Thickener

212

EXTENSIVELY HYDROLYSED FORMULA – Special Authority see SA1220 – Hospital pharmacy [HP3] Powder ................................................................................... 15.21 450 g OP ✔ Pepti Junior Gold Aptamil Gold Pepti Junior

Effective 1 May 2013

85 LEVOTHYROXINE Tab 50 mcg .............................................................................. 1.71 28 ✔ Goldshield Mercury Pharma ✔ Goldshield Mercury Pharma

‡ Safety cap for extemporaneously compounded oral liquid preparations. Tab 100 mcg............................................................................. 1.78 28 ‡ Safety cap for extemporaneously compounded oral liquid preparations.

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

27


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Section I

Effective 1 May 2013

224 INFLUENZA VACCINE – Hospital pharmacy [Xpharm] Inj ........................................................................................... 90.00 A) ✔ Fluarix ✔ Fluvax is available each year for patients who meet the following criteria, as set by PHARMAC: a) all people 65 years of age and over; b) people under 65 years of age with who: i) have the following cardiovascular disease: 1) ischaemic heart disease, 2) congestive heart disease, 3) rheumatic heart disease, 4) congenital heart disease, or 5) cerebo-vascular disease; ii) have the following chronic respiratory disease: 1) asthma, if on a regular preventative therapy, or 2) other chronic respiratory disease with impaired lung function; iii)are children aged four and under who have been hospitalised for respiratory illness or have a history of significant respiratory illness. iii)iv) have diabetes; iv)v) have chronic renal disease; v)vi) have any cancer, excluding basal and squamous skin cancers if not invasive; vi)vii)have any of the following other conditions: a) autoimmune disease, b) immune suppression, c) HIV, d) transplant recipients, e) neuromuscular and CNS diseases, f) haemoglobinopathies, or g) are children on long term aspirin; or vii)h)are pregnancy pregnant. c) people under 18 years of age living within the boundaries of the Canterbury District Health Board d) are children aged four and under who have been hospitalised for respiratory illness or have a history of significant respiratory illness Unless meeting other the criteria above, the following conditions are excluded from funding: a) asthma not requiring regular preventative therapy, b) hypertension and/or dyslipidaemia without evidence of end-organ disease. Doctors are the only Contractors entitled to claim payment from the Funder for the supply of influenza vaccine to patients eligible under the above criteria for subsidised immunisation and they may only do so in respect of the influenza vaccine listed in the Pharmaceutical Schedule. Individual DHBs may fund patients over and above the above criteria. The claiming process for these additional patients should be determined between the DHB and Contractor. Stock of the seasonal influenza vaccine is typically available from February until late July with suppliers being required to ensure supply until at least 30 June. Exact start and end dates for each season will be notified each year. 10

B) C) D)

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

28

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 June 2013

53 AMIODARONE HYDROCHLORIDE Inj 50 mg per ml, 3 ml ampoule – Up to 6 inj available on a PSO..................................................................................... 60.84 BEZAFIBRATE ❋Tab 200 mg ............................................................................... 9.70 STAVUDINE [D4T] – Special Authority see SA1025 – Retail pharmacy Cap 30 mg ........................................................................... 377.80 DICLOFENAC SODIUM ❋Tab EC 25 mg ............................................................................ 1.63 ❋Tab EC 50 mg ........................................................................... 1.60 (2.13) DOMPERIDONE ❋Tab 10 mg – For domperidone oral liquid formulation refer, page 188 ............................................................................... 3.25 (11.99) PROMETHAZINE HYDROCHLORIDE ❋‡ Oral liq 5 mg per 5 ml ............................................................. 2.79 (3.10) PHARMACY SERVICES ❋Brand switch fee ........................................................................ 4.33

10 90 60 50 50

✔Cordarone-X ✔ Fibalip ✔ Zerit ✔ Diclofenac Sandoz Diclofenac Sandoz

59 104 109

130

100 Motilium 100 ml Promethazine Winthrop Elixir 1 fee ✔ BSF Accarb ✔ BSF Ava 20 ED ✔ BSF Entapone ✔ BSF Zetlam

176

186

Effective 1 May 2013

24 CALCIUM CARBONATE WITH AMINOACETIC ACID ❋ Tab 420 mg with aminoacetic acid 180 mg – Higher subsidy of $6.30 per 100 tab with Endorsement ......................................................................... 3.00 100 (6.30) Titralac Additional subsidy by endorsement is available for pregnant women. The prescription must be endorsed accordingly. MICONAZOLE Oral gel 20 mg per g ................................................................ 4.95 (8.70) RIVAROXABAN – Special Authority see SA1066 – Retail pharmacy Tab 10 mg ............................................................................ 306.00 40 g OP Daktarin 30 ✔ Xarelto

40

47

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

29


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 May 2013 (continued)

57 DILTIAZEM HYDROCHLORIDE Cap long-acting 120 mg ............................................................ 1.91 (4.34) Cap long-acting 180 mg ........................................................... 2.86 (6.50) Cap long-acting 240 mg ........................................................... 3.81 (8.67) SILDENAFIL – Special Authority see SA1293 – Retail pharmacy Tab 25 mg ............................................................................. 39.00 Tab 50 mg ............................................................................. 43.50 Tab 100 mg – For sildenafil oral liquid formulation refer, page 179 ............................................................................. 47.00 CALCIPOTRIOL Oint 50 mcg per g .................................................................. 20.20 Soln 50 mcg per ml ................................................................ 33.79 4 4 4 30 g OP 60 ml OP

Cardizem CD Cardizem CD Cardizem CD ✔ Viagra ✔ Viagra ✔ Viagra ✔ Daivonex ✔ Daivonex

63

72

89

AZITHROMYCIN – Maximum of 5 days treatment per prescription; can be waived by endorsement For Endorsement, patient has either: i) Received a lung transplant and requires treatment or prophylaxis for bronchiolitis obliterans syndrome *; or ii) Cystic fibrosis and has chronic infection with Pseudomonas aeruginosa or Pseudomonas related gram negative organisms * Indications marked with * are Unapproved Indications Tab 500 mg – Up to 8 tab available on a PSO ............................ 1.25 2 OP ✔ Arrow-Azithromycin PAMIDRONATE DISODIUM Inj 3 mg per ml, 10 ml ............................................................ 16.00 (37.50) Inj 6 mg per ml, 10 ml ............................................................ 32.00 (75.00) Inj 9 mg per ml, 10 ml ............................................................ 48.00 (112.50) TYLOXAPOL ❋ Eye drops 0.25% ..................................................................... 8.63 1 Pamisol 1 Pamisol 1 Pamisol 15 ml OP ✔ Enuclene ✔ Neocate Advance

113

185 212

AMINO ACID FORMULA – Special Authority see SA1219 – Hospital pharmacy [HP3] Powder (tropical) .................................................................... 53.00 400 g OP

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

30

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 July 2013

49 DEXTROSE WITH ELECTROLYTES Soln with electrolytes................................................................. 6.60 6.75 PHARMACY SERVICES ❋ Brand switch fee ....................................................................... 4.33 1,000 ml OP ✔ Pedialyte - Fruit ✔ Pedialyte - Plain 1 fee ✔ BSF Alphapharm

186

Effective 1 August 2013

178 SALBUTAMOL ‡ Oral liq 2 mg per 5 ml ................................................................ 1.20 1.99 PHARMACY SERVICES - May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33 90 ml 150 ml 1 fee ✔ Broncolin S29 ✔ Ventolin ✔ BSF Apo-Diltiazem CD

186

Effective 1 October 2013

45 SODIUM TETRADECYL SULPHATE ❋ Inj 0.5% 2 ml ...................................................................... 23.20 (51.00) ❋ Inj 1% 2 ml ......................................................................... 25.00 (55.00) 5 Fibro-vein 5 Fibro-vein

88

CEFOXITIN SODIUM – Retail pharmacy-Specialist – Subsidy by endorsement Only if prescribed for dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. Inj 1 g .................................................................................. 55.00 5 ✔ Mayne CEFUROXIME SODIUM Inj 250 mg – Maximum of 3 inj per prescription; can be waived by endorsement ....................................................... 20.97 10 ✔ Mayne Waiver by endorsement must state that the prescription is for dialysis or cystic fibrosis patient. Inj 1.5 g – Retail pharmacy-Specialist – Subsidy by endorsement ......................................................................... 2.65 1 ✔ Mylan 4.04 ✔ Zinacef Only if prescribed for dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. FUSIDIC ACID Inj 500 mg sodium fusidate per 10 ml – Retail pharmacySpecialist – Subsidy by endorsement ................................... 12.87 1 (17.80) Fucidin Only if prescribed for a dialysis or cystic fibrosis patient and the prescription is endorsed accordingly. HOMATROPINE HYDROBROMIDE ❋ Eye drops 2% ........................................................................ 7.18 15 ml OP ✔ Isopto Homatropine

89

92

184

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

31


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Effective 1 November 2013

181 211 SODIUM CROMOGLYCATE Nasal spray, 4% ..................................................................... 15.85 22 ml OP ✔ Rex

AMINOACID FORMULA WITHOUT PHENYLALANINE – Special Authority see SA1108 – Hospital pharmacy [HP3] Sachets (tropical) ................................................................. 324.00 30 ✔ Phlexy 10

Effective 1 December 2013

31 75 INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE – Maximum of 100 dev per prescription ❋ Syringe 0.3 ml with 31 g × 8 mm needle ................................ 13.00 100 ✔ ABM CONDOMS ❋ 53 mm extra strength – Up to 144 dev available on a PSO ......... 1.11 13.36 METHYLCELLULOSE Powder .................................................................................. 14.00 12 144 100 g ✔ Gold Knight ✔ Gold Knight

193

✔ ABM

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

32

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II

Effective 1 June 2013

16 16 20 AMIODARONE HYDROCHLORIDE Inj 50 mg per ml, 3 ml ampoule – 1% DV Aug-13 to 2016 ....... 22.80 AMINOACID WITHOUT PHENYLALANINE Powder (unflavoured), 29 g ................................................... 330.12 BOSENTAN Tab 62.5 mg ...................................................................... 2,000.00 Tab 125 mg ....................................................................... 2,000.00 DAUNORUBICIN (addition of HSS) Inj 2 mg per ml, 10 ml – 1% DV Aug-13 to 2016 ................... 118.72 HIGH FAT LOW CARBOHYDRATE FORMULA Powder (unflavoured) .............................................................. 35.50 6 30 60 60 1 300 g Cordarone-X PKU Anamix Junior pms-Bosentan pms-Bosentan Pfizer KetoCal 4:1

27 37 39

INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE (delisting) Syringe 0.3 ml with 31 g × 8 mm needle ................................ 13.00 100 ABM Note – ABM syringe 0.3 ml with 31 g x 8 mm needle to be delisted from 1 August 2013 MACROGOL 3350 Powder 13.125 g, sachets ....................................................... 18.14 MACROGOL 3350 (HSS suspension) Powder 13.125 g, sachets – 1% DV Dec-12 to 31/05/13.................................................. 10.00 METHYLCELLULOSE (delisting) Powder .................................................................................. 14.00 Note – ABM powder to be delisted from 1 July 2013 SALBUTAMOL (delisting) Oral liq 2 mg per 5 ml ............................................................... 1.20 Note – Broncolin oral liq 2 mg per 5 ml to be delisted 1 July 2013 Sugammadex Inj 100 mg per ml, 2 ml ...................................................... 1,200.00 Inj 100 mg per ml, 5 ml ...................................................... 3,000.00 30 Movicol

43 43

30 100 g

Lax-Sachets ABM

45

59

90 ml

Broncolin

62

10 10

Bridion Bridion

Effective 1 May 2013

16 AMISULPRIDE ( price and addition of HSS) Tab 100 mg – 1% DV Jul-13 to 2016 ........................................ 6.22 Tab 200 mg – 1% DV Jul-13 to 2016 ...................................... 21.92 Tab 400 mg – 1% DV Jul-13 to 2016 ...................................... 44.52 Oral liq 100 mg per ml – 1% DV Jul-13 to 2016 ...................... 52.50 30 60 60 60 ml Solian Solian Solian Solian

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

33


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II – effective 1 May 2013 (continued)

17 AMOXYCILLIN (delisting) Drops 100 mg per ml ................................................................ 4.00 Note – Ospamox drops 100 mg per ml to be delisted from 1 July 2013 CEFOTAXIME (delisting) Inj 2 g ....................................................................................... 2.60 Note – Cefotaxime Sandoz inj 2 g to be delisted from 1 July 2013 CLONIDINE HYDROCHLORIDE Tab 25 mcg – 1% DV Jul-13 to 2015 ...................................... 15.09 Note – Dixarit tab 25 mcg to be delisted 1 July 2013 CODEINE PHOSPHATE ( price and addition of HSS) Tab 15 mg – 1% DV Jul-13 to 2016 .......................................... 4.75 Tab 30 mg – 1% DV Jul-13 to 2016 .......................................... 5.80 Tab 60 mg – 1% DV Jul-13 to 2016 ........................................ 12.50 DORIPENEM (delisting) Vial for infusion 500 mg ....................................................... 454.50 Note – Doribax vial for infusion 500 mg to be delisted from 1 July 2013 LEVONORGESTREL Tab 1.5 mg – 1% DV Jul-13 to 2016 ......................................... 3.50 Note – Next Choice tab 750 mcg to be delisted 1 July 2013 30 ml Ospamox

22

1

Cefotaxime Sandoz

25

112

Clonidine BNM

26

100 100 100 10

PSM PSM PSM Doribax

29

42

1

Postinor-1

42

LIGNOCAINE HYDROCHLORIDE LIDOCAINE [LIGNOCAINE] HYDROCHLORIDE (amended chemical name) Pump spray 10%, 50 ml CFC-free – 1% DV Nov-10 to 2013 .................................................... 75.00 50 ml Xylocaine Viscous soln 2% – 1% DV Sep-11 to 2014 .............................. 55.00 200 ml Xylocaine Viscous Inj 1%, 2 ml ............................................................................ 57.60 50 Xylocaine Inj 1%, 5 ml ............................................................................. 35.00 50 Xylocaine Inj 1%, 5 ml – 1% DV Jul-13 to 2015 ........................................ 8.75 25 Lidocaine-Claris Inj 1%, 20 ml .......................................................................... 20.00 5 Xylocaine Inj 1%, 20 ml – 1% DV Jul-13 to 2015 ...................................... 2.40 1 Lidocaine-Claris Inj 2%, 2 ml ............................................................................ 62.40 50 Xylocaine Inj 2%, 5 ml ............................................................................. 23.00 50 Xylocaine Inj 2%, 5 ml – 1% DV Jul-13 to 2015 ........................................ 6.90 25 Lidocaine-Claris Inj 2%, 20 ml .......................................................................... 15.00 5 Xylocaine Inj 2%, 20 ml – 1% DV Jul-13 to 2015 ...................................... 2.40 1 Lidocaine-Claris Note – Xylocaine inj 1% 2 ml, 1% 5 ml, 1% 20 ml, 2% 2 ml, 2% 5 ml, 2% 20 ml to be delisted 1 July 2013. MICONAZOLE NITRATE (delisting) Powder 2%................................................................................ 8.50 Note – Daktarin powder 2% to be delisted from 1 July 2013 30 g Daktarin

46

7

MORPHINE SULPHATE (delisting) Inj 1 mg per ml, 30 ml prefilled syringe ................................... 75.00 10 Note - Biomed inj 1 mg per ml, 30 ml prefilled syringe to be delisted from 1 July 2013.

Biomed

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

34


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II – effective 1 May 2013 (continued)

52 PERINDOPRIL Tab 2 mg .................................................................................. 3.75 Tab 4 mg .................................................................................. 4.80 30 30 Apo-Perindopril Apo-Perindopril Diprivan

55

PROPOFOL (delisting) Inj 2%, 50 ml prefilled syringe .................................................. 60.00 1 Note – Diprivan Inj 2%, 50 ml prefilled syringe to be delisted from 1 July 2013. RETINOL PALMITATE (delisting) Oint 25 g .................................................................................. 2.00 Oint 50 g .................................................................................. 2.86 Note – PSM and healthE oint 25 g and 50 g to be delisted from 1 July 2013.

57

1 1

PSM healthE

61

SODIUM HYALURONATE (amendment to line item description) Ophthalmic inj 14 mg per ml, 0.55 ml – 1% DV Oct-12 to 2015 ..................................................... 50.00 1 Healon GV Ophthalmic inj 14 mg per ml, 0.85 ml – 1% DV May-13 to 2015 ................................................... 50.00 1 Healon GV Note – Clarification of line description with a new Pharmacode applied to the new presentation. SORBOLENE WITH GLYCERIN ( price) Crm with 10% glycerine, 100 g ................................................. 2.72 Crm with 10% glycerine, 500 ml ............................................... 5.46 1 1 healthE healthE

61

Effective 1 April 2013

18 19 19 24 BACLOFEN ( price and addition of HSS) Tab 10 mg - 1% DV Jun-13 to 2016.......................................... 3.85 BENZBROMARONE Tab 100 mg ............................................................................ 45.00 BISMUTH TRIOXIDE Tab 120 mg ............................................................................ 32.50 CHLORTHALIDONE (delisting) Tab 25 mg ................................................................................ 4.80 Note – Igroton tab 25 mg to be delisted from 1 June 2013 DIAZOXIDE Cap 25 mg ............................................................................ 110.00 Cap 100 mg .......................................................................... 280.00 DOCETAXEL (new listing and change to HSS) Inj 20 mg – 1% DV Sep-11 to 30 April 2013 ............................ 48.75 Inj 20 mg – 1% DV May-13 to 2014 ........................................ 48.75 Inj 80 mg – 1% DV Sep-11 to 30 April 2013 .......................... 195.00 Inj 80 mg – 1% DV May-13 to 2014 ...................................... 195.00 100 100 112 30 Pacifen Benzbromaron De-Nol Igroton

28

100 100 1 1 1 1

Proglicem Proglicem Docetaxel Ebewe Docetaxel Sandoz Docetaxel Ebewe Docetaxel Sandoz

29

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

35


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II – effective 1 April 2013 (continued)

37 37 GLYCERYL TRINITRATE Oint 0.2% ................................................................................ 22.00 HIGH FAT LOW CARBOHYDRATE FORMULA Powder (vanilla) (amendment to brand name) .......................... 35.50 Powder (unflavoured) .............................................................. 35.50 NITAZOXANIDE Tab 500 mg ........................................................................ 1680.00 NORTRIPTYLINE HYDROCHLORIDE ( price and addition of HSS) Tab 10 mg - 1% DV Jun-13 to 2016.......................................... 4.00 Tab 25 mg - 1% DV Jun-13 to 2016.......................................... 9.00 OXYBUTYNIN (addition of HSS) Tab 5 mg - 1% DV Jun-13 to 2016 ( price)............................ 11.20 Oral liq 5 mg per 5 ml - 1% DV Jun-13 to 2016 ( price) ......... 56.45 PARA-AMINO SALICYLIC ACID Grans for oral liq 4 g sachet ................................................... 280.00 PAROMOMYCIN Cap 250 mg .......................................................................... 126.00 PEGASPARGASE Inj 3,750 IU per 5 ml........................................................... 3,005.00 PROTIONAMIDE Tab 250 mg .......................................................................... 305.00 STIRIPENTOL Cap 250 mg .......................................................................... 509.29 Powder for oral liq 250 mg sachet ......................................... 509.29 TETRACYCLINE Cap 500 mg ............................................................................ 46.00 30g 300 g 300 g Rectogesic KetoCal 4:1 KetoCal 3:1

50 50

30 100 180 500 473 ml 30 16 1 100 60 60 30

Alinia Norpress Norpress Apo-Oxybutynin Apo-Oxybutynin Paser Humatin Oncaspar Peteha Diacomit Diacomit Tetracyclin Wolff

52

53 53 53 56 63

63

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

36


Index

Pharmaceuticals and brands A Acarbose ........................................................... 21 Accarb ............................................................... 21 Alinia ................................................................. 36 Amino acid formula ............................................ 30 Aminoacid formula without phenylalanine ..... 20, 32 Aminoacid without phenylalanine ........................ 33 Amiodarone hydrochloride ................................. 33 Amiodarone hydrochloride ............................ 24, 29 Amisulpride .................................................. 24, 33 Amoxycillin ........................................................ 34 Apo-Diltiazem CD ............................................... 22 Apo-Oxybutynin ................................................. 36 Apo-Perindopril ...................................... 20, 22, 35 Aptamil feed thickener ........................................ 27 Aptamil Gold Pepti Junior ................................... 27 Ava 20 ED .......................................................... 21 Azithromycin ...................................................... 30 B Baclofen ............................................................ 35 Benzbromaron ................................................... 35 Benzbromarone .................................................. 35 Bezafibrate ......................................................... 29 Biltricide ............................................................. 24 Bismuth trioxide ................................................. 35 Bosentan ..................................................... 20, 33 Bridion ............................................................... 33 Broncolin ..................................................... 31, 33 BSF Accarb ........................................................ 29 BSF Alphapharm ................................................ 31 BSF Apo-Diltiazem CD .................................. 20, 31 BSF Ava 20 ED ................................................... 29 BSF Entapone .................................................... 29 BSF Zetlam ........................................................ 29 C Calamine ............................................................ 24 Calcipotriol ......................................................... 30 Calcium carbonate with aminoacetic acid ........... 29 Cardizem CD ...................................................... 30 Cefotaxime ......................................................... 34 Cefotaxime Sandoz ............................................ 34 Cefoxitin sodium ................................................ 31 Cefuroxime sodium ............................................ 31 Chlorafast .......................................................... 21 Chloramphenicol ................................................ 21 Chlorthalidone .................................................... 35 Cipflox ............................................................... 23 Ciprofloxacin ...................................................... 23 Ciprofloxacin Rex ............................................... 23 Clindamycin ....................................................... 23 Clindamycin ABM ............................................... 23 Clonidine BNM ............................................. 20, 34 Clonidine hydrochloride ................................ 20, 34 Condoms ........................................................... 32 Cordarone .......................................................... 24 Cordarone-X ................................................ 29, 33 Codeine phosphate ...................................... 24, 34 Coversyl ...................................................... 22, 24 D Daunorubicin ..................................................... 33 De-Nol ............................................................... 35 Dextrose with Electrolytes .................................. 31 Diacomit ............................................................ 36 Diazoxide ........................................................... 35 Diclofenac Sandoz ............................................. 29 Diclofenac sodium ............................................. 29 Diltiazem hydrochloride ................................ 22, 30 Diprivan ............................................................. 35 Docetaxel ........................................................... 35 Docetaxel Ebewe ................................................ 35 Docetaxel Sandoz ............................................... 35 Domperidone ..................................................... 29 Doribax .............................................................. 34 Doripenem ......................................................... 34 Daivonex ............................................................ 30 Daktarin ....................................................... 29, 34 Dalacin C ........................................................... 23 E Entacapone ........................................................ 21 Entapone ........................................................... 21 Enuclene ............................................................ 30 Ethinyloestradiol with Levonorgestrel .................. 21 Extensively hydrolysed formula ........................... 27 F Fibalip ................................................................ 29 Fibro-vein ........................................................... 31 Fluarix ................................................................ 28 Fluvax ................................................................ 28 Food Thickener .................................................. 27 Fucidin ............................................................... 31 Fusidic acid ........................................................ 31 G Glyceryl trinitrate ................................................ 36 Gold Knight ........................................................ 32 Goldshield .......................................................... 27 Gopten ............................................................... 22

37


Index

Pharmaceuticals and brands H Healon GV .......................................................... 35 High fat low carbohydrate formula .......... 20, 33, 36 Homatropine hydrobromide ................................ 31 Home Essential .................................................. 24 Humatin ............................................................. 36 Hydralazine hydrochloride .................................. 20 I Igroton ............................................................... 35 Influenza vaccine ................................................ 28 Insulin syringes, disposable with attached needle .... ...................................................................... 32, 33 Isoniazid ............................................................ 23 Isopto carpine .................................................... 21 Isopto homatropine ............................................ 31 Itraconazole ....................................................... 23 Itrazole ............................................................... 23 K Karicare food thickener ....................................... 27 KetoCal 3:1 ........................................................ 36 KetoCal 4:1 ............................................ 20, 33, 36 L Lamivudine ........................................................ 21 Lax-Sachets ....................................................... 33 Levonorgestrel ............................................. 24, 34 Levothyroxine .................................................... 27 Lidocaine-Claris ..................................... 20, 23, 34 Lidocaine [lignocaine] hydrochloride ...... 20, 23, 34 Lignocaine hydrochloride ............................. 23, 34 M Macrogol ........................................................... 33 Macrogol 3350 ............................................ 20, 33 Malathion with permethrin and piperonyl butoxide .... ...................................................................... 20, 24 Mercury Pharma ................................................ 27 Methylcellulose ...................................... 24, 32, 33 Metolazone .................................................. 20, 21 Metamide ........................................................... 21 Metoclopramide hydrochloride ........................... 21 Metopirone ........................................................ 24 Metyrapone ........................................................ 24 Miconazole ........................................................ 29 Miconazole nitrate .............................................. 34 MidWest ............................................................ 24 Morphine sulphate .............................................. 34 Movicol ........................................................ 20, 33 N Neocate Advance ............................................... 30 Nitazoxanide ...................................................... 36 Norpress ............................................................ 36 Nortriptyline hydrochloride .................................. 36 O Oncaspar ........................................................... 36 Ospamox ........................................................... 34 Oxybutynin ......................................................... 36 P Pacifen .............................................................. 35 Pamidronate disodium ....................................... 30 Pamisol ............................................................. 30 Para-amino salicylic acid .................................... 36 Para Plus ..................................................... 20, 24 Paromomycin .................................................... 36 Paser ................................................................. 36 Pedialyte - Fruit .................................................. 31 Pedialyte - Plain ................................................. 31 Pegaspargase .................................................... 36 Pepti Junior Gold ................................................ 27 Perindopril ....................................... 20, 22, 24, 35 Peteha ............................................................... 36 Pharmacy services ................................. 20, 29, 31 Phlexy 10 ........................................................... 32 Pilocarpine ......................................................... 21 PKU Anamix Junior ...................................... 20, 33 PMS-Bosentan ................................................... 20 Postinor-1 .................................................... 24, 34 Praziquantel ....................................................... 24 Proglicem .......................................................... 35 Promethazine winthrop elixir ............................... 29 Promethazine hydrochloride ............................... 29 Propofol ............................................................. 35 Protionamide ...................................................... 36 R Rectogesic ......................................................... 36 Retinol palmitate ................................................ 35 Rifinah ............................................................... 23 Rivaroxaban ....................................................... 29 S Salbutamol ................................................... 31, 33 Sildenafil ............................................................ 30 Sodium cromoglycate ........................................ 32 Sodium hyaluronate ........................................... 35 Sodium tetradecyl sulphate ................................ 31 Solian .......................................................... 24, 33 Sorbolene with glycerin ...................................... 35 Stavudine [D4t] .................................................. 29 Stiripentol .......................................................... 36 Sugammadex ..................................................... 33

38


Index

Pharmaceuticals and brands T Tetracycline ....................................................... 36 Tetracyclin Wolff ................................................ 36 Titralac .............................................................. 29 Trandolapril ........................................................ 22 Tyloxapol ........................................................... 30 V Ventolin ............................................................. 31 Viagra ................................................................ 30 X Xarelto ............................................................... 29 Xylocaine ..................................................... 23, 34 Xylocaine Viscous ........................................ 23, 34 Z Zaroxolyn ..................................................... 20, 21 Zerit ................................................................... 29 Zetlam ............................................................... 21 Zinacef ............................................................... 31

39


Index

Pharmaceuticals and brands

40


Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-9376 (Print) ISSN 1179-3686 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

If Undelivered, Return To: PO Box 10-254, Wellington 6143, New Zealand

Metadata

Title

Schedule Update - effective 1 June 2013

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 June 2013 Cumulative for May and June 2013 Section H cumulative for April, May and June 2013 Contents Summary of PHARMAC decisions effective 1 June 2013 ….. 3 Blood glucose…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.